Pirbright and ViroVet join forces to develop African swine fever antivirals

Researchers at The Pirbright Institute will partner with the Belgian biotechnology company ViroVet to develop the first antiviral drugs that act against African swine fever (ASF).
calendar icon 29 May 2019
clock icon 3 minute read
In the absence of a vaccine, antiviral drugs could provide an alternative control method which would help limit clinical signs in pigs and lower ASF virus replication
In the absence of a vaccine, antiviral drugs could provide an alternative control method which would help limit clinical signs in pigs and lower ASF virus replication
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.